KORU Medical Systems Stock - Analyst consensus and small-cap medtech context

KORU Medical Systems stock sits in a niche of home infusion devices, with a moderate-buy analyst consensus and a small-cap valuation on Nasdaq. A look at current expectations, sector backdrop and the business model behind the KRMD ticker.

Edited by ad hoc news Sector & Peer-Group Desk. Verified prior to publication on 06/19/2026, 20:10 UTC. Details in the imprint.

KORU Medical Systems (US5006311063) operates as a small-cap medical technology stock specializing in home infusion systems on Nasdaq. With no fresh corporate filings today, the focus for investors shifts to the analyst consensus and the broader medtech peer group.

What the analyst consensus shows

For KORU Medical Systems, data compiled by MarketBeat show a consensus rating of "Moderate Buy" from five covering analysts, with an average price target of $7.25 per share. The individual targets span a range from $6.00 to $8.00.

Relative to a recent closing price of $3.90 on 06/18/2026, the average target implies upside potential of roughly 86% if estimates materialize. Consensus metrics are, however, based on forward-looking assumptions that can change quickly with new quarterly results.

How KRMD compares in medtech

KORU Medical Systems sits in the medical instruments and supplies space, alongside much larger peers in the Standard & Poor's 500 index such as Baxter, Becton Dickinson or ResMed, which operate with significantly higher scale and diversified product portfolios.

Unlike these large caps, KRMD's business is narrowly focused on subcutaneous drug delivery at home, leaving the company more exposed to single product lines and reimbursement decisions, but also giving it a clearly defined niche in the infusion market.

The product behind the stock

The core of KORU Medical Systems' business is the Freedom60 syringe infusion system, used primarily for subcutaneous administration of immunoglobulin therapies in home settings. The system includes dedicated syringes and precision flow rate tubing sets as part of an integrated platform.

Where the stock trades today

The shares of KORU Medical Systems (US5006311063) last closed on Nasdaq at $3.90 as of 06/18/2026, 04:00 PM Eastern Time.

Key facts on KORU Medical Systems stock

• Company: KORU Medical Systems Inc.
• ISIN: US5006311063
• WKN: A2QE6W
• Ticker: KRMD
• Venue: Nasdaq
• Price (as of 06/18/2026, 04:00 PM Eastern Time): 3.90 USD
• Market cap: approximately 193 million USD (as of 06/18/2026, based on MarketBeat data and recent share price)
• Sector / Industry: Health Care / Medical Instruments & Supplies
• Index membership: not a member of major benchmark indices such as the S&P 500 or Nasdaq-100
• Next earnings date: not officially scheduled; the prior quarterly release was published on 05/06/2026 according to company filings.

This article was AI-assisted and editorially reviewed. Price and company data without warranty; prices and dates may change at short notice. No investment advice, no buy or sell recommendation. Trading securities involves risk up to total loss of capital.